Oromucosal Liquid Estradiol Compositions
AssigneeInnotesto Bvba
InventorFranciscus Wilhelmus Henricus Maria Merkus
Life of this patent
Estimating the term…
Abstract
The present invention relates to low dose estradiol solutions for oromucosal administration suitable in replacement therapy or suppletion of low estradiol levels and also for preventing, alleviating or treating symptoms associated with low endogenous levels of estradiol in female subjects.
Claims11
1-20. (canceled)
A method of treating a human female patient having reduced estradiol levels, said method comprising administering oromucosally to a human female patient in need thereof one or more doses of a solution comprising 0.01-0.9% (w/v) of estradiol, or an equivalent amount of a pharmaceutically acceptable hydrate or ester thereof, 5-30% (v/v) of ethanol and 70-95% (v/v) of an ester of a C2-6 alcohol and a C8-22 fatty acid;
- wherein said dose comprises 0.01-0.3 mg of estradiol, or an equivalent amount of a pharmaceutically acceptable hydrate or ester thereof, wherein the solution is administered 1-6 times per day by spray, by drops or by a dosage pen, and wherein the solution does not contain water.
Dependencies are inferred from the claim text.